HEMATOLOGICAL RECOVERY AFTER HIGH-DOSE CYCLOPHOSPHAMIDE (CTX) AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT)

被引:0
|
作者
TWELVES, CJ
SOUHAMI, RL
HARPER, PG
GOLDSTONE, A
机构
[1] GUYS HOSP, CLIN ONCOL UNIT, LONDON SE1 9RT, ENGLAND
[2] UNIV COLL HOSP LONDON, DEPT ONCOL, LONDON WC 1, ENGLAND
[3] UNIV COLL HOSP LONDON, DEPT HAEMATOL, LONDON WC 1, ENGLAND
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:276 / 277
页数:2
相关论文
共 50 条
  • [41] BONE-MARROW (BM) PROCESSING AND CRYOPRESERVATION FOR AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT)
    GARCIA, J
    AYATS, R
    MADOZ, P
    SARDA, P
    PASTORET, C
    VILA, L
    MARTINEZ, E
    RUTLLANT, ML
    EXPERIMENTAL HEMATOLOGY, 1985, 13 : 51 - 51
  • [42] TOXICITY OF HIGH-DOSE BUSULFAN AND CYCLOPHOSPHAMIDE AS CONDITIONING THERAPY FOR ALLOGENEIC BONE-MARROW TRANSPLANTATION IN ADULTS WITH HEMATOLOGICAL MALIGNANCIES
    BANDINI, G
    BELARDINELLI, A
    ROSTI, G
    CALORI, E
    MOTTA, MR
    RIZZI, S
    BENINI, C
    TURA, S
    BONE MARROW TRANSPLANTATION, 1994, 13 (05) : 577 - 581
  • [43] AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IN MALIGNANT GLIOMA
    PHILLIPS, GL
    FAY, JW
    HERZIG, GP
    HERZIG, RH
    LAZARUS, HM
    WOLFF, SN
    INTERNATIONAL JOURNAL OF CELL CLONING, 1985, 3 (04): : 257 - 257
  • [44] RHG-CSF HASTENS GRANULOCYTE RECOVERY IN HODGKINS-DISEASE AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANT (ABMT)
    TAYLOR, K
    SPITZER, G
    JAGANNATH, S
    DICKE, K
    VINCENT, M
    SOUZA, L
    EXPERIMENTAL HEMATOLOGY, 1988, 16 (06) : 413 - 413
  • [45] GRANULOCYTE COLONY-STIMULATING FACTOR AND NEUTROPHIL RECOVERY AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    SHERIDAN, WP
    WOLF, M
    LUSK, J
    LAYTON, JE
    SOUZA, L
    MORSTYN, G
    DODDS, A
    MAHER, D
    GREEN, MD
    FOX, RM
    LANCET, 1989, 2 (8668): : 891 - 895
  • [46] TOXICITY OF HIGH-DOSE BUSULFAN AND CYCLOPHOSPHAMIDE AS A PREPARATIVE REGIMEN FOR BONE-MARROW TRANSPLANTATION
    KASAI, M
    KIYAMA, Y
    WATANABE, M
    SETO, K
    MATSUURA, A
    TANAKA, J
    TAKEDA, H
    NAOHARA, T
    HIGA, T
    HASHINO, S
    KOBAYASHI, H
    KOBAYASHI, M
    IMAMURA, M
    SAKURADA, K
    MIYAZAKI, T
    TRANSPLANTATION PROCEEDINGS, 1992, 24 (04) : 1529 - 1530
  • [47] PROLONGED IMPAIRMENT OF HEMATOPOIESIS AFTER HIGH-DOSE THERAPY FOLLOWED BY AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    DOMENECH, J
    LINASSIER, C
    GIHANA, E
    DAYAN, A
    TRUGLIO, D
    BOUT, M
    PETITDIDIER, C
    DELAIN, M
    PETIT, A
    BREMOND, JL
    DESBOIS, I
    LAMAGNERE, JP
    COLOMBAT, P
    BINET, C
    BLOOD, 1995, 85 (11) : 3320 - 3327
  • [48] HIGH-DOSE CYCLOPHOSPHAMIDE WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION AS INITIAL TREATMENT OF SMALL CELL BRONCHOGENIC-CARCINOMA
    SOUHAMI, RL
    HARPER, PG
    GOLDSTONE, AH
    TOBIAS, JS
    RICHARDS, JDM
    SPIRO, SG
    GEDDES, DM
    EXPERIMENTAL HEMATOLOGY, 1983, 11 : 171 - 171
  • [49] TRANSIENT NEPHROGENIC DIABETES-INSIPIDUS FOLLOWING HIGH-DOSE CYCLOPHOSPHAMIDE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    FINN, G
    DENNING, D
    CANCER TREATMENT REPORTS, 1987, 71 (02): : 220 - 221
  • [50] HIGH-DOSE CYCLOPHOSPHAMIDE OR MELPHALAN WITH ESCALATING DOSES OF MITOXANTRONE AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR REFRACTORY SOLID TUMORS
    MULDER, POM
    SLEIJFER, DT
    WILLEMSE, PHB
    DEVRIES, EGE
    UGES, DRA
    MULDER, NH
    CANCER RESEARCH, 1989, 49 (16) : 4654 - 4658